Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The U.S. government's principal agency for cancer research
In the study, the 5-year overall survival rate after a diagnosis of breast cancer was 77.6% for men, compared with 86.4% for women.
Scientists emphasize using data and analyses from completed and ongoing trials to gain a better understanding of patient outcomes.
Forty-five percent of 182 phase 3 clinical trials between 1980 and 2017 influenced guideline care or new drug approvals.
The study tested the effectiveness of CEASE, a program that aims to reduce children’s exposure to secondhand smoke by helping parents quit.
A new study suggests that, for people with pancreatic cancer, the makeup of the bacteria in their tumors could predict how long they live.
The researchers found that very few women reported discussing costs with their medical team, despite their desire to do so.
“We can speculate that there’s going to be all kinds of interesting nutritional interventions that could influence cancer.”
I’d like to invite the cancer community to consider what you will do to facilitate data-sharing for the benefit of children with cancer.
An overactive immune system is the main reason that many people with both cancer and autoimmune diseases aren’t included in clinical trials.
“Don’t eat me” proteins are “like invisibility cloaks for the cancer,” preventing white blood cells from detecting and devouring tum...
Investigators say their findings support annual blood tests for all individuals with MGUS.
New results confirm that the drug, Balversa (erdafitinib), can benefit people whose tumors have a certain genetic alteration.
Race-related differences in risk and smoking behaviors aren’t accounted for in current lung cancer screening recommendations.
New research suggests that inducing necroptosis in or around tumor cells can help the immune system rid the body of cancer cells.
The Cytophone device was able to detect a single cancer cell in a liter of blood.
The study’s findings open a window for very early detection of the disease and could help identify those who need more aggressive treatment.
Conclusions from four recent studies could open up potential strategies for boosting the effectiveness of cancer immunotherapies.
The study results, which have been presented at scientific meetings, are already a matter of debate among oncologists.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.